Since 2003, class actions have been on the increase. Aggrieved shareholders have sought redress where the actions or inactions of companies like Myer, NAB, AWB,..
CMC Markets’ chief market strategist, Michael McCarthy, explains why he likes Appen (APX) but doesn’t like Xero (XRO).
With nearly 70% of the S&P 500 having reported, US companies are navigating reasonably well. Here’s a high level summary from analysts at Morgan Stanley in Ne..
Here are the 4 rules I follow when choosing small caps for yield and 3 stocks to consider for experienced income investors.
Despite a warning from Paul (Rickard) that many of our favourite dividend-paying stocks are likely to be less rewarding in the future, I went looking for 10 rel..
Aussie medical device companies such as Cochlear and ResMed are two global leaders in their space. Other home grown device companies are advancing their product..